Credi health Private Limited

Credi Health Private Limited is an online healthcare platform that connects patients with medical services, facilitating appointment bookings and consultations to simplify healthcare decisions and empower users with essential medical information. Founded in 2013, Credi Health Private Limited operates from Gurgaon, India, providing a platform that connects patients with healthcare providers. The company was established by Saurabh Uboweja, who has experience in entrepreneurship within the healthcare sector. In December 2018, Credi Health secured INR 43.

87 million in funding from Mountain Pine Capital, which contributed to its total fundraising of INR 43. 87 million. As of the latest information, the company is valued at INR 941. 40 million.

Credi Health primarily offers an online healthcare platform facilitating access to various medical services. The core product connects patients with healthcare providers, allowing users to book appointments and access consultations. The platform aims to empower families by providing extensive information on medical procedures, enhancing healthcare decision-making. Credi Health serves a diverse clientele, including patients with specific medical needs and families seeking reliable medical guidance, with active operations in major cities across India, such as Delhi, Mumbai, and Bengaluru, and international clients seeking medical treatment in India.

In the most recent year, 2022, Credi Health reported a revenue of INR 832,498. 30 and an EBITDA of INR 46,688. 80. The company's revenue model is built around direct-to-consumer transactions, charging clients for appointment bookings and medical consultations on a fee-for-service basis.

By arranging hospital admissions and coordinating with healthcare providers, Credi Health creates a robust network for delivering healthcare solutions, ensuring customer satisfaction through timely and effective service. Credi Health plans to leverage its recent funding of INR 43. 87 million from December 2018 to enhance its platform and expand service offerings. Although specific new products or release dates have not been disclosed, the funding is intended to support technological advancements in their service delivery.

The company is targeting expansion into new markets, focusing on regions both domestically and internationally, but specific geographic areas and timelines for this growth have not been specified. Continued development will aim to enhance patient experience and broaden access to healthcare services.